Doctor profile · Federal record
Dr. Minal Barve, M.D.
Medical Oncology Physician (CMS: Medical Oncology) · Dallas, TX
- NPI 1245277698
- Accepts Medicare
- MIPS 86.7 / 100 · 2023
- 33 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
8220 Walnut Hill Ln, Suite 700
Dallas, TX 752314427
(214) 739-4175
fax (214) 987-4161 - Mailing address
-
Po Box 911230
Dallas, TX 753911230
Credentials & registration
- NPI registered
- June 2006 — 20 yrs on file
- Profile last updated
- August 14, 2014
- Year of graduation
- 1993 — 33 yrs since
- Specialty taxonomy
- 207RX0202X — NUCC code
- State license (1)
- Texas #K9724
- Medicaid (3)
- OK #200164790A · TX #155499004 · TX #155499005
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1245277698. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
57,484
Distinct HCPCS
10
Medicare allowed
$1,006,842
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J9271 |
Injection, pembrolizumab, 1 mg | 11,400 | 29 | $54 | |
J1453 |
Injection, fosaprepitant, 1 mg | 9,300 | 42 | $0 | |
Q5101 |
Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram | 7,320 | 13 | $0 | |
J0881 |
Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 5,855 | 23 | $3 | |
J1756 |
Injection, iron sucrose, 1 mg | 5,600 | 20 | $0 | |
J9267 |
Injection, paclitaxel, 1 mg | 4,602 | 12 | $0 | |
J1568 |
Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | 2,300 | 15 | $42 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 1,108 | 62 | $0 | |
J0897 |
Injection, denosumab, 1 mg | 1,020 | 13 | $23 | |
36415 |
Insertion of needle into vein for collection of blood sample | 838 | 201 | $8 |
In context: peer comparison
Among 27 peers in Dallas Medical Oncology Physician, average services per provider: 1,011. This provider delivers 57× the peer median.Open Payments
Industry payments received
All-time total
$5,179
Transactions
23
Manufacturers
9
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Boehringer Ingelheim International GmbH | 12 | $4,748.50 | |
| Janssen Biotech, INC. | 2 | $164.39 | |
| Theratechnologies INC. | 1 | $64.74 | |
| Menarini Silicon Biosystems, INC. | 2 | $56.26 | |
| GlaxoSmithKline, LLC. | 2 | $44.42 | |
| Tempus Ai, INC | 1 | $28.78 | |
| AstraZeneca Pharmaceuticals Lp | 1 | $28.03 | |
| Merck Sharp & Dohme LLC | 1 | $23.69 | |
| Abbvie INC. | 1 | $20.33 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
471
Patients
23
Total drug cost
$1,494,331
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Acyclovir | Generic | 52 | 0 | $846 |
| Letrozole | Generic | 52 | 0 | $727 |
| Eliquis (Apixaban) | Brand | 47 | 0 | $34,530 |
| Xarelto (Rivaroxaban) | Brand | 40 | 0 | $33,012 |
| Revlimid (Lenalidomide) | Brand | 38 | 0 | $692,437 |
| Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) | Brand | 31 | 0 | $1,087 |
| Potassium Chloride | Generic | 31 | 12 | $681 |
| Prednisone | Generic | 31 | 11 | $174 |
| Imbruvica (Ibrutinib) | Brand | 25 | 0 | $427,593 |
| Meloxicam | Generic | 23 | 0 | $53 |
Hospital affiliations
Frequently asked questions
What is Dr. Minal Barve's medical specialty?
Dr. Minal Barve practices Medical Oncology Physician in Dallas, TX.
Where does Dr. Minal Barve practice?
Dr. Minal Barve practices at 8220 Walnut Hill Ln, Dallas, TX 752314427. Office phone: 2147394175.
What is Dr. Minal Barve's NPI?
Dr. Minal Barve's National Provider Identifier (NPI) is 1245277698, issued by NPPES.
Does Dr. Minal Barve accept Medicare assignment?
Yes. Dr. Minal Barve accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Minal Barve commonly perform?
Top Medicare-reported procedures in 2023: Injection, pembrolizumab, 1 mg (HCPCS J9271); Injection, fosaprepitant, 1 mg (HCPCS J1453); Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram (HCPCS Q5101). Source: CMS Medicare Physician & Other Practitioners file.